Total Payments
$15,465
2024 Payments
$3,890
Companies
30
Transactions
931
Medicare Patients
10,195
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$15,445 (99.9%)
Education$19.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,445 | 930 | 99.9% |
| Education | $19.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,744 | 248 | $0 (2024) |
| Amgen Inc. | $1,920 | 102 | $0 (2024) |
| UCB, Inc. | $1,828 | 124 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,348 | 80 | $0 (2024) |
| PFIZER INC. | $1,089 | 66 | $0 (2024) |
| Janssen Biotech, Inc. | $822.53 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $615.49 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $551.51 | 34 | $0 (2024) |
| GENZYME CORPORATION | $456.59 | 29 | $0 (2024) |
| Lilly USA, LLC | $423.79 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,890 | 212 | ABBVIE INC. ($985.65) |
| 2023 | $2,981 | 167 | ABBVIE INC. ($903.85) |
| 2022 | $2,698 | 166 | ABBVIE INC. ($673.26) |
| 2021 | $1,961 | 128 | AbbVie Inc. ($575.13) |
| 2020 | $831.40 | 60 | AbbVie Inc. ($175.09) |
| 2019 | $2,640 | 172 | Novartis Pharmaceuticals Corporation ($386.07) |
| 2018 | $463.14 | 26 | Celgene Corporation ($136.78) |
All Payment Transactions
931 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Immunology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Bone Health | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/04/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.13 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,310 | 56,517 | $1.3M | $440,215 |
| 2022 | 37 | 2,450 | 57,785 | $1.7M | $559,755 |
| 2021 | 31 | 2,692 | 36,068 | $1.2M | $458,020 |
| 2020 | 37 | 2,743 | 35,331 | $1.2M | $437,149 |
Total Patients
10,195
Total Services
185,701
Medicare Billing
$1.9M
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 13 | 24,993 | $271,560 | $116,865 | 43.0% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 18 | 3,450 | $310,500 | $116,207 | 37.4% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 19 | 23,000 | $345,000 | $89,797 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 663 | $165,750 | $55,812 | 33.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 29 | 117 | $58,500 | $11,008 | 18.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 259 | 581 | $17,430 | $5,986 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $12,480 | $4,602 | 36.9% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 73 | 76 | $11,400 | $4,589 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 78 | $13,650 | $4,526 | 33.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 256 | 572 | $14,300 | $4,329 | 30.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 251 | 503 | $6,036 | $4,187 | 69.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 31 | 70 | $9,100 | $3,259 | 35.8% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 74 | 274 | $8,180 | $3,120 | 38.1% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 266 | 607 | $10,926 | $3,064 | 28.0% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 21 | 147 | $8,085 | $2,486 | 30.7% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 266 | 607 | $6,070 | $1,598 | 26.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 15 | 67 | $10,050 | $1,382 | 13.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 121 | $4,235 | $1,288 | 30.4% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 45 | 90 | $2,700 | $1,017 | 37.7% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 22 | 72 | $3,240 | $789.29 | 24.4% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 15 | 51 | $2,025 | $757.96 | 37.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 14 | 50 | $1,690 | $629.90 | 37.3% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 37 | 37 | $1,665 | $469.53 | 28.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $420.00 | $404.18 | 96.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 13 | 26 | $975.00 | $398.39 | 40.9% |
About Dr. Stephen Elmore, MD
Dr. Stephen Elmore, MD is a Internal Medicine healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1467891564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Elmore, MD has received a total of $15,465 in payments from pharmaceutical and medical device companies, with $3,890 received in 2024. These payments were reported across 931 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($15,445).
As a Medicare-enrolled provider, Elmore has provided services to 10,195 Medicare beneficiaries, totaling 185,701 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Gainesville, GA
- Active Since 06/21/2013
- Last Updated 07/14/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467891564
Products in Payments
- RINVOQ (Biological) $2,179
- Cimzia (Drug) $1,700
- Enbrel (Biological) $1,230
- XELJANZ (Drug) $967.14
- COSENTYX (Biological) $853.69
- SKYRIZI (Biological) $793.40
- SAPHNELO (Biological) $593.96
- TREMFYA (Drug) $583.06
- ORENCIA (Biological) $551.51
- COSENTYX (Drug) $494.54
- TALTZ (Drug) $377.51
- BENLYSTA (Biological) $330.82
- KRYSTEXXA (Biological) $325.14
- LUPKYNIS (Drug) $318.68
- Humira (Biological) $283.70
- HUMIRA (Biological) $242.73
- SIMPONI ARIA (Biological) $205.41
- TAVNEOS (Drug) $199.62
- Otezla (Drug) $192.21
- KEVZARA (Drug) $185.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gainesville
Dr. Vivek Sambhara, M.d, M.D
Internal Medicine — Payments: $217,213
Internal Medicine $217,213
Dr. Christopher Recknor, M.d, M.D
Internal Medicine — Payments: $91,144
Internal Medicine $91,144
Dr. Carlos Alviar Restrepo, Md, MD
Internal Medicine — Payments: $90,926
Internal Medicine $90,926
Dr. Alanna Morris, M.d, M.D
Internal Medicine — Payments: $85,602
Internal Medicine $85,602
Brian Ramnaraign, M.d, M.D
Internal Medicine — Payments: $65,740
Internal Medicine $65,740
Ilie Barb, M.d, M.D
Internal Medicine — Payments: $55,024
Internal Medicine $55,024